Moneycontrol PRO
Outskill Genai
HomeNewsBusinessStartupIron Pillar raises $45 million add-on fund to back portfolio leaders

Iron Pillar raises $45 million add-on fund to back portfolio leaders

The VC firm will use the fund by the end of the year to back best-performing companies in its portfolio.

May 18, 2020 / 17:15 IST
Representative image

Iron Pillar, a firm which invests in growth-stage startups, said on May 18 it raised an add-on fund of $45 million to back the best-performing companies in its portfolio.

Iron Pillar is a venture capital (VC) firm that invests between $7-15 million as the first cheque in Series B and C rounds of companies.

“We expect to deploy this fund by the end of the year. Despite the Covid-19 pandemic, we have seen some of our companies double their sales numbers in the last one and a half months and this capital will help them,” Anand Prasanna, managing partner, Iron Pillar, told Moneycontrol.

COVID-19 is the respiratory illness caused by the coronavirus.

Founded in 2017 Prasanna, a former Morgan Creek director, former Citigroup India investment banking head Sameer Nath and former DFJ India head Mohanjit Jolly, it raised its debut fund of $90 million in 2018 to invest in technology-led startups.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

VCs are raising add-on funds so that when their portfolio firms raise large rounds, these early-backers are not left out and don't miss out on the upside because they have no more capital left to commit.

The fundraise also comes at a time when the venture capital industry, at large, is bracing for a slowdown in investments, exits and a period of crisis.

Some of this was already expected as high-profile startups, globally and in India, faced a reckoning since last year.

But the coronavirus pandemic made corrections in valuations and the slowdown much sharper.

Iron Pillar’s portfolio includes speech-recognition tech firm Uniphore, test-preparation startup Testbook, Vyome Therapeutics, which focuses on drug-resistant skin pathogens, jewellery-maker Bluestone and NowFloats that helps businesses with their online presence.

It has already seen an exit--somewhat early for a debut fund--when Reliance Industries Limited acquired NowFloats for $20 million in 2019.

Despite the pandemic, Prasanna said the firm was still evaluating new deals but whether they would finally invest was uncertain.

“We have been tracking some companies for years. But whether we will invest three months or even six months later is difficult to tell right now,” he said.

Invite your friends and family to sign up for MC Tech 3, our daily newsletter that breaks down the biggest tech and startup stories of the day

M. Sriram
M. Sriram
first published: May 18, 2020 05:00 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347